John D. Halamka, MD, MS, Editor-in-Chief

info@partnersindigitalhealth.com

John D. Halamka, MD, Chief Information Officer, Beth Israel Deaconess System,  Chairman, New England Healthcare Exchange Network (NEHEN),  International Healthcare Innovation Professor, Harvard Medical School, and practicing emergency physician.

Dr. Halamka completed his undergraduate studies at Stanford University, where he received a degree in medical microbiology and a degree in public policy with a focus on technology issues. He entered medical school at the University of California, San Francisco and simultaneously pursued graduate work in bioengineering at the University of California, Berkeley focusing on technology issues in medicine. He completed his residency at Harbor–UCLA Medical Center in the Department of Emergency Medicine.

In his role at BIDMC, Dr. Halamka is responsible for all clinical, financial, administrative, and academic information technology, serving 3,000 doctors, 12,000 employees, and 1,000,000 patients. As chairman of NEHEN, Dr. Halamka oversees clinical and administrative data exchange among the payers, providers, and patients in Massachusetts.   As a Harvard professor, he has served the George W. Bush administration, the Obama administration, and national governments throughout the world planning their healthcare IT strategy.

Dr. Halamka has authored five books on technology-related issues, hundreds of articles and thousands of posts on the popular Geekdoctor blog. He runs Unity Farm in Sherborn, MA and serves as caretaker for 150 animals, 30 acres of agricultural production and a cidery/winery.

Competing interests and/or Financial disclosure

Blockchain in Healthcare Today requires all board and staff members to disclose relevant financial relationships.  An individual has a relevant financial relationship if he/she and/or a spouse or partner had a financial relationship in any amount occurring in the last 12 months with a commercial interest. As such, the following interests are declared below.

Commercial interests:

  1. Arcadia Healthcare Solutions Advisory Board
  2. New Leaf Venture Partners Advisory Board
  3. Orion Healthcare Board of Directors
  4. Gates Foundation Consultant

 

Douglas Shinsato, Editor Emeritus 

 

Editorial Stewards

Combiz Richard Abdolrahimi, Emerging Technologies & Innovation Leader, Deloitte

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Gil Alterovitz, PhD, Faculty, Harvard Medical School/Boston Children's Hospital, Massachusetts Institute of Technology

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Mate Beštek, BSc, National Institute of Public Health, Center for Healthcare Informatics, Republic of Slovenia; Faculty, Computer and Information Dept., University of Ljubljana, Slovenia

Competing interests and/or Financial disclosure

I am Advisor to Iryo.io

 

Kevin A. Clauson, PharmD, Associate Professor, Lipscomb University College of Pharmacy & Health Sciences

Competing interests and/or Financial disclosure

I have served as a consultant through a third party consultancy for blockchain companies focused on healthcare and health care companies exploring blockchain solutions. I have fluid cryptoasset/cryptocurrency holdings.

 

Nitin Gaur, Director, IBM WW Digital Asset Labs at IBM

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Florence D. Hudson, Former IBM Vice President and Internet2 Senior Vice President and Chief Innovation Officer  

Competing interests and/or Financial disclosure

I get a pension from IBM. I am a PI on NSF #1650445 EAGER (Early Concept Grant for Exploratory Research): Cybersecurity Transition To Practices (TTP) Acceleration. I have received up to $1000 per diem honoraria to speak at conferences regarding IoT, cybersecurity and other topics. NSF sometimes pays my travel to meetings they ask me to attend, or which are supported by NSF EAGER #1650445, or other awards, in the U.S. and outside the U.S.. Occasionally regional networks, university and industry members of Internet2 (e.g., OSHEAN, Microsoft, Cisco, Stony Brook University), pay for my travel to participate in and speak at their events. The Swiss NSF has paid me to be a subject matter expert on a proposal. but I am editor-in-chief for a Springer Publications book to be published in 2019 in their Women in Engineering and Science Series, provisionally titled “Women in TIPPSS for IoT,” which is Trust, Identity, Privacy, Protection, Safety and Security for the Internet of Things. Royalties may also result from this initiative. I am on multiple academic boards with no remuneration, such as the NSF awarded CyberService cyber degree program with PIs at Union County College, the Industrial and Manufacturing Engineering Industry Advisory Board at Cal Poly San Luis Obispo, multiple boards and councils at my alma mater Princeton University, including the Princeton University Civil and Environmental Engineering Advisory Board, Princeton Technology Advisory Council, the Princeton University Infrastructure Master Plan Technical Advisory Group, and Gift Planning Chair for my Class. I have various stock interests, in funds, or directly and do not believe any are a conflict.

 

Mike Jacobs, Technology Fellow and SVP of Engineering, Optum

 Competing interests and/or Financial disclosure

  1. Employee of Optum (part of Unitedhealth Group)
  2. Stock shareholder of Unitedhealth Group (UNH)
  3. Holder of intellectual property rights and patents

 

Taha Kass-Hout, MD, MS, Former FDA Chief Health Informatics Officer

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

George Kolostoumpis, BSc, PhD, External Scientific Expert, ECDC; Technical Expert, EUREKA

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Tim Ken Mackey, MAS, PhD, Associate Professor of Anesthesiology and Global Public Health, UC San Diego School of Medicine and Director of Healthcare Research and Policy, UC San Diego

Competing interests and/or Financial disclosure

Tim K. Mackey serves as the Co-Chair for the IEEE Standards Association Supply Chain/Clinical Trials Technology Implementation Industry Connections Program, is an invited participant in the DSCSA & Blockchain Study by the Center for Supply Chain Studies, and is a member of the Advisory Board for the company FarmaTrust, a blockchain company developing technology for the pharmaceutical supply chain.

 

Manouchehr (Mitch) Mokhtari, PhD, Professor, School of Public Health, University of Maryland, College Park

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Jim NasrVice President, Technology & Innovation, Synchrogenix, a Certara company

Competing interests and/or Financial disclosure
I am an employee of Certara - a privately owned organization providing software and services to the life sciences and healthcare industry. I hold a limited range of cryptoassets.

 

Erik Pupo, Chief Information Officer, Columbia University Irving Medical Center

Competing interests and/or Financial disclosure

TBD

 

Mona Siddiqui, MDMPH, Chief Data Officer, Department of Health and Human Services (HHS)

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Tom Savel, MD, Director, Informatics Innovation Unit, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention (CDC)

Competing interests and/or Financial disclosure

I have fluid cryptoasset/cryptocurrency holdings.

 

Peer Reviewers

Debbie Bucci, IT Architect

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Bill Buchanan, OBE, Professor, School of Computing, Edinburgh Napier University; Fellow, BCS and IET

Competing interests and/or Financial disclosure

I have no commercial interests to disclose.

 

Vikram Dhillon, Research Fellow, Institute of Simulation and Training at University of Central Florida

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Cees Hesp, Director mHealth Research Labs, PharmAccess Foundation, and Director, Digital Impact Alliance (DIAL), United Nations Foundation

Competing interests and/or Financial disclosure

I am employed at PharmAccess, serve on the board of Directors of DIAL, and have an unpaid advisory role at SuretyBlock. SuretyBlock is a blockchain-based online insurance marketplace. I have no other commercial interests to disclose.

 

Louis O. Jeansonne IV, MD, Assistant Vice President for Medical Affairs, Ochsner Medical Center Baton Rouge

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Anh L. Ngo, MD, MBA, Faculty, Harvard Medical School, Beth Israel  Deaconess Medical Center, Department of Anesthesia, Critical Care, and Pain Medicine

Competing interests and/or Financial disclosure

I am the owner of Safety Medical Laboratories (safemedlabs.com)

 

Tina Penman, AuD, Regional Research Administrator, Department of Defense Hearing Center of Excellence (HCE), National Center for Rehabilitative Auditory Research (NCRAR), VA Portland Health Care System

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Dennis Porto MD, MPH, FAAD, is the Lewis Wendell Hackett award recipient at Harvard where he contributes to the blockchain and bitcoin curriculum at Harvard Business School. 

Competing interests and/or Financial disclosure

I have equity or agreements for future equity investments in several private companies to be disclosed upon request. I have equity investments in the following public companies: Google, Netflix, Amazon, and Facebook. I am an investor in artificial intelligence, robotics, and biotech exchange-traded funds. I own bitcoin. I am a peer-reviewer for JAMA Dermatology and the Journal of Cosmetic dermatology. I am an editor of the textbook Botulinum Toxins in Dermatology and do not receive royalty.

 

Karl A. Poterack, MD, Medical Director, Applied Clinical Informatics, Mayo Clinic, Associate Medical Information Officer, Mayo Clinic Arizona
and Assistant Professor of Anesthesiology, Mayo Clinic College of Medicine

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Ana Santos Rutschman, Assistant Professor of Law, Center for Health Law Studies, Saint Louis University School of Law

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Amanda Stanhaus is a Health Management and Policy Ph.D. student at The University of Michigan. Formerly,  J.P.Morgan’s Blockchain strategist for Quorum.

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Jin Wei-Kocsis, Ph.D., Assistant Professor, Department of Electrical and Computer Engineering, Auburn Science and Engineering Center, The University of Akron

Competing interests and/or Financial disclosure

I have no commercial interests to declare.

 

Publishing and Operations Staff

Tory Cenaj
Founder, Owner, and Publisher, Partners in Digital Health
info@partnersindigitalhealth.com

Competing interests and/or Financial disclosure

I am the founder and owner of Partners in Digital Health, including the journals Blockchain in Healthcare Today, Telehealth and Medicine Today, all related activities and initiatives associated with these titles, and company portfolio. I volunteer for, and own, SolarCoin.

 

John Russo Jr., PharmD, Managing Editor

jdr3366@gmail.com

Competing interests and/or Financial disclosure

I am the owner of The MedCom Resource.

 

Ron Ribitzky MD, Marketing & UX Strategy Advisor

Competing interests and/or Financial disclosure

Founder & CEO of R&D Ribitzky, Boston, MA, a services group specializing in Digital Health and Precision Medicine market worldwide. Expert Reviewer. Skolkovo Foundation BioMed and ICT Clusters Healthcare & Life Sciences Practice Lead, Digital Health Organizer of Innovative Care Asia Pacific. Strategic Advisor and Agenda Moderator, AMTEC-KAZAN / ICO Summit & Competition; Skolkovo Open Innovations, Skolkovo School of Management Member, HIMSS Blockchain Taskforce; HIMSS Blockchain Symposium Organizing Committee Reviewer and Mentor, HIMSS19 Precision Medicine & Genomics. Lead author, blockchain article published on BHTY. Contributing author of AI in Pharma article published on PharmaExec.com.

Competing interests and/or Financial disclosure

Stock shareholder of iSpecimen. Business Partner of DEMTECH.biz, East-West Digital News, ACTIMIRA., and TALENTGRID VENTURES.  Strategic Advisor and token rights holder ARNA Genomics, BitMED. MarketsandMarkets Honorarium recipient.  Komodo Health